Onelife Capital Advisors Limited has successfully completed its rights issue journey with the receipt of official listing and trading approvals from both BSE and NSE. The Mumbai-based financial services company announced on March 25, 2026, that it has received formal approval for trading of 2.40 crore equity shares allotted through its rights issue.

Exchange Approvals and Trading Commencement

The company received comprehensive approvals from both major stock exchanges for its rights issue shares. The regulatory clearances mark the final step in the company's capital raising initiative.

Rights Issue Performance Summary

The rights issue demonstrated exceptional investor confidence with strong subscription metrics across all categories. The company successfully raised Rs. 360.00 crores through this capital raising exercise.

Subscription and Allotment Breakdown

The issue period ran from February 23, 2026 to March 16, 2026, with robust participation from both eligible shareholders and renouncees.

Regulatory Compliance and Documentation

The company has completed all regulatory formalities in accordance with SEBI ICDR Regulations 2018. Key compliance milestones include dispatch of allotment advice, credit of equity shares to demat accounts, and ASBA fund unblocking instructions, all completed by March 23, 2026.

Company Profile

Onelife Capital Advisors Limited, incorporated in 2007 and converted to public limited status in 2010, operates as a financial services company with its registered office in Thane, Maharashtra. The company's promoters are Prabhakar Naig and Pandoo Naig. The newly allotted shares will trade exclusively in dematerialized form on both BSE (Scrip Code: 533632) and NSE (Symbol: ONELIFECAP).

Onelife Capital Advisors Limited has successfully completed a significant rights issue allotment worth ₹36.00 crore, marking a major milestone in the company's capital expansion plans. The Board of Directors of the Rights Issue Committee approved the allotment of equity shares on March 17, 2026, following regulatory compliance and consultation with relevant authorities.

Rights Issue Allotment Details

The company has allotted 2,40,00,000 rights equity shares with specific pricing and premium structure. The allotment was conducted in accordance with the Letter of Offer dated February 10, 2026, and the basis of allotment was finalized in consultation with BSE Limited, which served as the designated stock exchange for this rights issue.

Capital Structure Transformation

The rights issue has resulted in a substantial increase in the company's paid-up equity share capital. This expansion represents a significant enhancement to the company's capital base and financial structure.

Board Meeting and Regulatory Compliance

The Rights Issue Committee's Board of Directors meeting was conducted on March 17, 2026, commencing at 07:00 P.M. and concluding at 07:30 P.M. The meeting was chaired by Prabhakara Naig, who serves as Chairperson and Whole Time Director of the company. The allotment was approved in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The company has formally notified both BSE Limited and National Stock Exchange of India Limited about the completion of the rights issue allotment. This communication ensures transparency and regulatory compliance, keeping all stakeholders informed about the significant corporate action and its impact on the company's capital structure.